William Panje invented the neolarynx restoring speech to cancer patients who have had their larynxes removed
In 1981, University of Iowa researcher William Panje introduced the neolarynx, or “voice button,” restoring speech to cancer…
In 1981, University of Iowa researcher William Panje introduced the neolarynx, or “voice button,” restoring speech to cancer…
In 1981, the National Cancer Institute (NC) awarded The City of Hope Cancer Center NCI-designation. City of Hope’s…
In 1981, the La Jolla Cancer Research Foundation, the Cancer Center received its National Cancer Institute (NCI)-designation. The…
In 1981, Stanford oncologist Ronald Levy reported the first successful use of monoclonal antibodies, which are laboratory-created molecules…
In 1981, John Wayne Cancer Institute (formerly known as the John Wayne Cancer Clinic) was founded to promote…
In 1981, Hybritech issued its Initial Public Offering (IPO) and raised $12 million, and $33 million in a…
In 1981, The University of Hawaii Cancer Center (UH Cancer Center) was founded. The UH Cancer Center’s mission…
On Dec. 17, 1980, the Health Programs Extension Act of 1980 (P.L. 96-538), introduced by Sen. Edward Kennedy,…
On Jul. 9, 1980, Dr. Vincent T. DeVita, Jr. became the ninth director of the National Cancer Institute…
In 1980, The Holden Cancer Center at University of Iowa was founded with Richard L. DeGowin, M.D. appointed…
In 1980, the $2 million Gershenson Radiation Oncology Center (GROC) opened as a partnership between Wayne State University’s…
On Jul. 18, 1979, the National Cancer Institute and the National Naval Medical Center, Bethesda, Md., signed an…
On May 10, 1979, ground was broken for the University of Southern Califrona Kenneth Norris Jr. Cancer Hospital…
In 1979, the most frequently mutated gene in human cancer, p53, was identified by six groups of researchers…
In 1979, Modified radical mastectomy replaced radical mastectomy for breast cancer. The standard of care for patients with…
In 1979, Dr. Norman H. Cromwell of the Department of Chemistry, University of Nebraska-Lincoln, became acting director of…
On Nov. 9, 1978, the President Jimmy Carter signed the Community Mental Health Centers Act (P.L. 95-622) amending…
On Nov. 9, 1978, the first human testing of a biological therapy was conducted (alpha-interferon). The Cancer Research…
In 1978, Tamoxifen, an anti-estrogen drug, was approved by the FDA for the treatment of breast cancer. Tamoxifen…
In 1978, the U.S. Food and Drug Administration (FDA) approved cisplatin (Platinol) for use in combination with other…
In 1978, The University of Arizona Cancer Center (UACC) received its first National Cancer Institute (NCI) Support Grant…
In 1978, the University of California, San Diego Cancer Center was founded as one of just 45 National…
In 1978, Hybritech was founded by cancer researcher Ivor Royston and lab technician Howard Birndorf of the University…
In 1978, the National Cancer Institute (NCI) awarded the Cancer Center of Metropolitan Detroit with comprehensive status. Known…
In 1978, Wayne State Universityï¾’s School of Medicine researcher Dr. Norman Nigro discovered a link between dietary fiber…
In 1978, the Norris Cotton Cancer Center in New Hampshire received National Cancer Institute (NCI) designated in recognition…
In 1978, Bristol-Myers introduced anticancer agents PLATINOL and LYSODREN (mitotane).
In 1978, the Carbone Cancer Center Clinical Sciences Center was completed in January adding over 70,000 square feet…
In 1978, the University of Kentucky (UK) Markey Cancer Foundation, previously the Ephraim McDowell Cancer Research Foundation, was…
In December 1977, Tamoxifen (Nolvadex, Soltamox) was approved by the Food and Drug Administration (FDA) for use in…